Transgenic mouse model of malignant skin melanoma
- PMID: 8415613
- PMCID: PMC47451
- DOI: 10.1073/pnas.90.19.8817
Transgenic mouse model of malignant skin melanoma
Abstract
Tyr-SV40E transgenic mice are specifically susceptible to melanoma due to expression of the oncogene in pigment cells. Mice of the more susceptible lines die young of early-onset eye melanomas, when skin melanomas are still infrequent and benign. To surmount this obstacle, skin from donors of two high-susceptibility lines was grafted to Tyr-SV40E hosts of a low-susceptibility line of the same inbred strain, thereby enabling the skin to outlive the donors and continue to grow in immunocompetent but tolerant hosts. Unexpectedly, donor pigment cells in all the grafts soon selectively proliferated close to areas of greatest wound healing, forming a dense black tracery, especially at the outer rim of the grafts. These lesions slowly grew radially within the grafts, producing irregular greyish patches. Local vertical thickenings then appeared and developed into small melanomas, which soon ulcerated through the epidermis. The tumors rapidly enlarged and became deeply invasive. Discrete black nevi also arose, with many becoming larger and distinctly blue, but those not near areas of pronounced wound healing did not progress to malignancy. In this first series, malignant melanoma resulted in all the grafts from the more susceptible of two donor lines and in some grafts from the other line. Distant metastases occurred in some cases from each line. Most tumors were hypomelanotic and heterogeneous, with lobes or areas differing in melanization. The results strongly suggest that growth factors and cytokines--known to be produced in wound repair--are triggering the growth and malignant conversion of these genetically susceptible melanocytes and that in the graft situation we are merely witnessing a caricature--a usefully exaggerated manifestation of the true events underlying the genesis of melanomas. The striking resemblance to the human malignancy, the genetic uniformity and different susceptibilities of the transgenic lines, and the experimental possibilities in the grafted mice all make them an excellent model of the disease.
Similar articles
-
Histopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice.Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8822-6. doi: 10.1073/pnas.90.19.8822. Proc Natl Acad Sci U S A. 1993. PMID: 8415614 Free PMC article.
-
Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.Oncogene. 1993 Mar;8(3):523-31. Oncogene. 1993. PMID: 8382353
-
Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes.Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9534-8. doi: 10.1073/pnas.89.20.9534. Proc Natl Acad Sci U S A. 1992. PMID: 1329100 Free PMC article.
-
Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.Photochem Photobiol Sci. 2006 Feb;5(2):254-60. doi: 10.1039/b506974b. Epub 2005 Jul 27. Photochem Photobiol Sci. 2006. PMID: 16465311 Review.
-
Blue nevus-like and blue nevus-associated melanoma: a comprehensive review of the literature.ANZ J Surg. 2017 May;87(5):345-349. doi: 10.1111/ans.13946. Epub 2017 Mar 20. ANZ J Surg. 2017. PMID: 28318130 Review.
Cited by
-
Development of a syngeneic mouse model of epithelial ovarian cancer.J Ovarian Res. 2010 Oct 19;3:24. doi: 10.1186/1757-2215-3-24. J Ovarian Res. 2010. PMID: 20958993 Free PMC article.
-
Modeling Melanoma In Vitro and In Vivo.Healthcare (Basel). 2013 Dec 23;2(1):27-46. doi: 10.3390/healthcare2010027. Healthcare (Basel). 2013. PMID: 27429258 Free PMC article. Review.
-
Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy.Environ Health Perspect. 2000 Mar;108 Suppl 1(Suppl 1):71-8. doi: 10.1289/ehp.00108s171. Environ Health Perspect. 2000. PMID: 10698724 Free PMC article. Review.
-
Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.Oncogene. 2017 Jun 29;36(26):3789-3795. doi: 10.1038/onc.2016.511. Epub 2017 Feb 13. Oncogene. 2017. PMID: 28192409
-
Histopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice.Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8822-6. doi: 10.1073/pnas.90.19.8822. Proc Natl Acad Sci U S A. 1993. PMID: 8415614 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases